White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Adults with Severe or Moderately Severe Hemophilia B and AAV5 Antibodies

Recruiting

3 1 1 1
Investigated Diseases:
- Factor IX deficiency
Investigated Drugs:
- Etranacogene Dezaparvovec
Study Comparing Surgery and Chemoradiotherapy with Capecitabine for Early Rectal Cancer Patients

Recruiting

3 1 1 1
Investigated Drugs:
- Capecitabine
Study on the Safety and Effectiveness of C1 Esterase Inhibitor and Sodium Chloride for Patients with Aneurysmal Subarachnoid Hemorrhage

Recruiting

2 1 1
Investigated Diseases:
- Subarachnoid haemorrhage
Investigated Drugs:
- C1 Esterase Inhibitor (Human)
- Sodium Chloride
Study on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events

Recruiting

3 1 1
Investigated Drugs:
- Colchicine
- Carbasalate Calcium
Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

Recruiting

3 1
Investigated Diseases:
- Sickle cell disease
Investigated Drugs:
- Etavopivat
Study of 99mTc-MIP-1404 SPECT/CT imaging compared to standard imaging methods for detecting lymph node metastases in patients with prostate cancer

Recruiting

4 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
Study on the Safety of Intradermal mRNA COVID-19 Vaccine Bretovameran for Patients with Fibrodysplasia Ossificans Progressiva

Recruiting

3 1 1 1
Investigated Diseases:
- Fibrodysplasia ossificans progressiva
Study on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on Eltrombopag for Treating Low and Intermediate Risk Myelodysplastic Syndromes in Patients with Thrombocytopenia

Recruiting

2 1 1 1
Investigated Drugs:
- Eltrombopag
Study on Liver Fibrosis Assessment Using 68Ga-FAPI-46 Imaging in Patients with Suspected or Confirmed Nonalcoholic Steatohepatitis

Recruiting

2 1 1
Investigated Diseases:
- Metabolic dysfunction-associated steatohepatitis
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies